Skip to main content

Table 1 Clinical characteristics of studied patients

From: Characteristics of COVID and post COVID polyneuropathies in adults and pediatrics: an Egyptian sample

 

Frequency

Neuropathy

AIDP (motor and sensory)

25 (59.5%)

 

AMSAN

8 (19%)

 

Demyelinating with secondary axonal

5 (11.9%)

 

CIDP like

4 (9.5%)

CT chest

Normal

2 (4.8%)

Interstitial pneumonia

3 (7.1%)

Interstitial pneumonia without parenchymal opacity

4 (9.5%)

Bilateral GGO

33 (78.6%)

PCR

Positive

36 (85.7%)

CBC

Lymphopenia

30 (71.4%)

CRP

Elevated

31 (73.8%)

Outcome

Full Improvement

31 (73.8)

No improvement and needed second treatment to improve

8 (19%)

Minimal improvement

3 (7.1%)

 

Total

42 (100%)

  1. AIDP acute inflammatory demyelinating polyneuropathy, AMSAN acute motor sensory axonal neuropathy, CIDP chronic inflammatory demyelinating polyneuropathy, CT computed tomography, GGO ground glass opacity, CBC complete blood count, CRP C reactive protein